Skip to main content
Top

06-24-2015 | Retinopathy | Article

Feasibility and efficacy of diabetic retinopathy screening among youth with diabetes in a pediatric endocrinology clinic: a cross-sectional study

Journal: Diabetology & Metabolic Syndrome

Authors: Jeffrey L. Tapley, Gerald McGwin Jr., Ambika P. Ashraf, Paul A. MacLennan, Koula Callahan, Karen Searcey, C. Douglas Witherspoon, Jinan Saaddine, Cynthia Owsley

Publisher: BioMed Central

Abstract

Background

We examined the feasibility and efficacy of using a non-mydriatic camera to screen for diabetic retinopathy (DR) among youth with type 1 or type 2 diabetes seen in a pediatric endocrinology clinic serving Alabama, the state that has the highest diabetes rate in the United States.

Methods

236 youths with type 1 or type 2 diabetes were screened for DR using a non-mydriatic camera. Visual acuity was also assessed. A questionnaire asked parents about diabetes and eye care history.

Results

Mean duration since diabetes diagnosis was 5.5 years. 66 % reported receiving an eye examination within the previous year. 97.5 % had images that were gradable. DR was detected in 3.8 % of participants. 9.1 % were visually impaired.

Conclusions

Use of a non-mydriatic fundus camera is feasible and efficacious for DR screening in youth with diabetes. DR screening at routine endocrinology visits may be beneficial in managing youth with diabetes and preventing irreversible vision loss, particularly for those in regions where diabetes rates are high.
Literature
1.
Dabelea D, Mayer-Davis EJ, Saydah S, Imperatore G, Linder B, Divers J, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001–2009. JAMA. 2014;311:1778–86.PubMedCentralPubMedCrossRef
2.
American Diabetes Association. Standards of medical care in diabetes – 2014. Diabetes Care. 2014;37 Suppl 1:S14–80.CrossRef
3.
Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984;102:520–6.PubMedCrossRef
4.
Fong DS, Aiello LM, Gardner TW, King GI, Blankenship G, Cavallerano JD, et al. Retinopathy in diabetes. Diabetes Care. 2004;27(Suppl):S84–S7.PubMedCrossRef
5.
Raczynska D, Zorena K, Urban B, Zaleski D, Slorek A, Maulkiewicz G, et al. Current trends in the monitoring and treatment of diabetic retinopathy in young adults. Mediators Inflamm. 2014;2014:492926.PubMedCentralPubMedCrossRef
6.
Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy: ETDRS report number 9. Ophthalmology. 1991;98(Suppl):766–85.
7.
Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: diabetic retinopathy vitrectomy study report 5. Arch Ophthalmol. 1990;108:958–64.
8.
Hamman RF, Bell RA, Dabelea D, D’Agostino RBJ, Dolan L, Imperatore G, et al. The SEARCH for Diabetes in Youth study: rationale, findings, and future directions. Diabetes Care. 2014;37:3336–44.PubMedCrossRef
9.
Waitzfelder B, Pihoker C, Klingensmith G, Case D, Anderson AJ, Bell RA, et al. Adherence to guidelines for youths with diabetes mellitus. Pediatrics. 2011;128:531–8.PubMedCentralPubMed
10.
Lin DY, Blumenkranz MS, Brothers RJ, Grosvenor DM. The sensitivity and specificity of single-field monmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. Am J Ophthalmol. 2002;134:204–13.PubMedCrossRef
11.
Massin P, Erginay A, Mehidi AB, Vicaut E, Quentel G, Victor Z, et al. Evaluation of a new non-mydriatic digital camera for detection of diabetic retinopathy. Diabet Med. 2003;20:635–41.PubMedCrossRef
12.
Bragge P, Gruen RL, Chau M, Forbes A, Taylor HR. Screening for presence or absence of diabetic retinopathy: a meta-analysis. Arch Ophthalmol. 2011;129:435–44.PubMedCrossRef
13.
Stillman JK, Gole GA, Wootton R, Woolfield N, Price D, Van der Westhuyzen J, et al. Telepaediatrics and diabetic retinoapthy screening of young people with diabetes in Queensland. J Telemed Telecare. 2004;10(Suppl):92–4.PubMedCrossRef
14.
Kolomeyer AM, Nayak NV, Simon MA, Szirth BC, Shahid K, Sheng IY, et al. Feasibility of retinal screening in a pediatric population with type 1 diabetes. J AAPOS. 2014;51:299–306.
15.
Minuto N, Emmanuele V, Vannati M, Russo C, Rebora C, Panarello S, et al. Retinopathy screening in patients with type 1 diabetes diagnosed in young age using non-mydriatic digital sterescopic retinal imaging. J Endocrinol Invest. 2012;35:389–94.PubMed
16.
Alabama Department of Public Health. Diabetes in Alabama. Alabama Department of Public Health, Montgomery, AL 2010. https://​adph.​org/​diabetes/​assets/​DiabetesinALRepo​rt09.​pdf. Accessed 23 Mar 2015.
17.
Harding SP, Greenwood R, Adlington S, Gibson J, Owens DA, Talylor R, et al. Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabet Med. 2003;20:965–71.PubMedCrossRef
18.
American Academy of Ophthalmology Preferred Practice Patterns Committee. Preferred Practice Pattern Guidelines. Comprehensive Adult Medical Eye Evaluation 2010. American Academy of Ophthalmology, San Francisco CA. http://​www.​aao.​org/​preferred-practice-pattern/​comprehensive-adult-medical-eye-evaluation--octobe. Accessed 23 June 2015.
19.
Daniels SR, Greer FR. Lipid screening and cardiovascular health in childhood. Pediatrics. 2008;122:198–208.PubMedCrossRef
20.
Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care. 2011;34:e61–99.PubMedCentralPubMedCrossRef
21.
Peters A, Davidson MB, Ziel FH. Cost-effective screening for diabetic retinopathy using a nonmydriatic reitnal camera in a prepaid health-care setting. Diabetes Care. 1993;16:1193–5.PubMedCrossRef
22.
Scanlon PH, Malhotra R, Thomas G, Foy C, Kirkpatrick JN, Lewis-Garned N, et al. The effectiveness of screening for diabetic retinopathy by digital imaging photography and technician ophthalmoscopy. Diabet Med. 2003;20:467–74.PubMedCrossRef
23.
Scanlon PH, Foy C, Malhotra R, Aldington SJ. The influence of age, duration of diabetes, cataract, and pupil size on image quaity in digital photographic retinal screening. Diabetes Care. 2005;28:2448–53.PubMedCrossRef
24.
Valent D, Pestak K, Otis M, Shubrook J. Type 2 diabetes in the pediatric population: are we meeting ADA clinical guidelines in Ohio. Clin Pediatr. 2010;49:316–22.CrossRef
25.
Dumser SM, Ratcliffe SJ, Langdon DR, Murpphy KM, Lipman TH. Racial disparities in screening for diabetic retinopathy in you with type 1 diabetes. Diabetes Res Clin Pract. 2013;101:e3–5.PubMedCrossRef
26.
Schoenfeld ER, Greene JM, Wu SY, Leske C. Patterns of adherence to diabetes vision care guidelines. Ophthalmology. 2001;108:563–71.PubMedCrossRef
27.
Rosenberg JB, Friedman IB, Gurland JE. Compliance with screening guidelines fo diabetic retinopathy in a large academic children’s hospital in the Bronx. J Diabetes Complications. 2011;25:222–6.PubMedCrossRef
28.
Scanlon PH. The English National Screening Programme for sight threatening retinopathy. J Med Screen. 2008;15:1–4.PubMedCrossRef
29.
Jones S, Edwards RT. Diabetic retinopathy screening: a systematic review of the economic evidence. Diabet Med. 2010;27:249–56.PubMedCrossRef
30.
Huo B, Steffen AT, Swan K, Sikes K, Weinzimer SA, Tamborlane WV. Clinical outcomes and cost-effectiveness of retinopathy screening in youth with type 1 diabetes. Diabetes Care. 2007;30:362–3.PubMedCrossRef
31.
Lueder GT, Silverstein J. Screening for retinopathy in the pediatric patient with type 1 diabetes mellitus. Pediatrics. 2005;116:270–3.PubMedCrossRef
32.
Donaghue KC, Fairchild JM, Chan A, Hing SJ, King J, Howard NJ, et al. Diabetes microvascluar complications in prepubertal children. J Pediatr Endocrinol Metab. 1997;10:579–85.PubMed
33.
Holl RW, Lang A, Grabert M, Heinze E, Lang GK, Debatin KM. Diabetic retinopathy in pediatric patients with type-1 diabetes: effect of diabetes duration, prepubertal and pubertal onset of diabetes, and metabolic control. J Pediatr. 1998;132:790–4.PubMedCrossRef
34.
Forlenza GP, Steward MW. Diabetic retinopathy in children. Pediatr Endocrinol Rev. 2012;10:217–26.PubMed

Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform. 

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »